HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

So 1100

oil containing 70.2% linoleic acid and 8.7% gamma-linolenic acid

Also Known As:

So-1100

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Essential Fatty Acids: 734
      - Linolenic Acids: 96
        gamma-Linolenic Acid: 351
        So 1100: 2
      - Linoleic Acids: 78
        So 1100: 2
    - Omega-6 Fatty Acids: 555
      - gamma-Linolenic Acid: 351
        So 1100: 2
      - Linoleic Acids: 78
        So 1100: 2

Related Diseases

1.	Necrosis 07/01/1993 - "Late skin damage, assessed in terms of late erythema or dermal necrosis, was also reduced with So-1100, with DMFs of 1.14-1.51. " 12/01/1994 - "A 3.0 ml daily dose of either So-1100 or So-5407 given prior to, but also after irradiation with single and fractionated doses of beta-rays produced the most significant modification to the radiation reactions, effects consistent with dose modification factors between 1.06-1.24 for the acute reactions of bright red erythema and/or moist desquamation, and of 1.14-1.35 for the late reactions of dusky/mauve erythema and dermal necrosis. "
2.	Erythema 07/01/1993 - "The severity of the acute reaction, assessed in terms of erythema or moist desquamation, was significantly less in those pigs that received So-1100 both before and after irradiation, as compared with those receiving that oil only prior to irradiation and the 'placebo' groups. " 07/01/1993 - "Late skin damage, assessed in terms of late erythema or dermal necrosis, was also reduced with So-1100, with DMFs of 1.14-1.51. " 12/01/1994 - "A 3.0 ml daily dose of either So-1100 or So-5407 given prior to, but also after irradiation with single and fractionated doses of beta-rays produced the most significant modification to the radiation reactions, effects consistent with dose modification factors between 1.06-1.24 for the acute reactions of bright red erythema and/or moist desquamation, and of 1.14-1.35 for the late reactions of dusky/mauve erythema and dermal necrosis. "

Related Drugs and Biologics

1.	So 5407